Theory of mind and facial emotion recognition in euthymic bipolar I and bipolar II disorders

Theory of mind and facial emotion recognition in euthymic bipolar I and bipolar II disorders
复制标题

DOI:
10.1016/j.psychres.2011.04.033
复制
发表时间:
2011-10-30
影响因子:
11.3
通讯作者:
Igoa, Ana
Igoa, Ana
中科院分区:
医学2区
文献类型:
--
作者:
Javier Martino, Diego;Adrian Strejilevich, Sergio;Igoa, Ana

文献摘要

被引文献

相似文献

本研究的主要目的是比较双相双相(BDI)和双相II(BDII)障碍患者和健康对照的社会认知水平。其他目的是探索社会认知表现与神经认知障碍和心理社会功能之间的联系。BDI或BDII患者81例,健康对照组34例。所有受试者都完成了评估言语记忆、注意力和执行功能的测试。此外,还包括心理理论(Tom)和面部情绪识别测量。用GAF评定心理社会功能。两组患者在TOM上的表现都低于健康对照组,对恐惧面部表情的识别能力也较低。当神经认知障碍和药物暴露被控制时,Tom的表现和对恐惧面部表情的识别不能预测受试者是患者还是健康对照组。社会认知测量不会增加神经认知损伤解释之外的差异,它们也不是心理社会功能的独立预测因子。面部情绪识别和心理理论的障碍至少部分是由注意力-执行功能缺陷和精神药物的接触所调节的。同样,社会认知测量对神经认知障碍以外的差异没有贡献。(C)2011爱思唯尔爱尔兰有限公司。保留所有权利。
The main aim of this study was to compare patients with euthymic bipolar I (BDI) and bipolar II (BDII) disorders and healthy controls in measures of social cognition. Additional aims were to explore the association between social cognition performance with neurocognitive impairments and psychosocial functioning. Eighty one euthymic patients with BDI or BDII and 34 healthy controls were included. All subjects completed tests to assess verbal memory, attention, and executive functions. Additionally theory of mind (TOM) and facial emotion recognition measures were included. Psychosocial functioning was assessed with the GAF. Both groups of patients had lower performance than healthy controls in ToM, and a lower recognition of fear facial expression. When neurocognitive impairments and exposure to medications were controlled, performance in ToM and recognition of fear facial expression did not allow predicting if a subject was patient or healthy control. Social cognition measures not enhance variance beyond explained by neurocognitive impairments and they were not independent predictors of psychosocial functioning. Impairments in facial emotion recognition and ToM are mediated, at least partly, by attention-executive functions deficits and exposure to psychotropic medications. Likewise, social cognition measures did not contribute to variance beyond neurocognitive impairments. (C) 2011 Elsevier Ireland Ltd. All rights reserved.